KEY FEATURES
| Full Name | Involucrin |
|---|---|
| Synonym | IVL |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human INV in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human INV. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human INV and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human INV, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human INV. You can calculate the concentration of Human INV in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES
TYPICAL DATA
Human INV ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 1.11 | 2.8 | 6.78 | 1.13 | 2.91 | 7.26 |
| Standard deviation | 0.07 | 0.14 | 0.36 | 0.06 | 0.17 | 0.32 |
| CV(%) | 6.36 | 5.11 | 5.26 | 5.4 | 5.79 | 4.46 |
RECOVERY
The recovery of Human INV spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-100 | 93 |
| EDTA plasma (n=8) | 88-98 | 93 |
| Cell culture media (n=8) | 94-108 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human INV in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.
Products associated with INV ELISA Kits
| LOR ELISA Kit | publications with INV and LOR |
| SPRR3 ELISA Kit | publications with INV and SPRR3 |
| JUNB ELISA Kit | publications with INV and JUNB |
| KRT1 ELISA Kit | publications with INV and KRT1 |
Pathways associated with INV ELISA Kit
| Corticotropin-releasing Hormone Pathway | Corticotropin-releasing Hormone Pathway |
| Validated Transcriptional Targets Of AP1 Family Members Fra1 And Fra2 Pathway | Validated Transcriptional Targets Of AP1 Family Members Fra1 And Fra2 Pathway |
Diseases associated with INV ELISA Kit
| Immune System Diseases | publications with INV and Immune System Diseases |
| Skin Neoplasms | publications with INV and Skin Neoplasms |
| Leiomyoma | publications with INV and Leiomyoma |
| Brain Diseases | publications with INV and Brain Diseases |
| Lung Neoplasms | publications with INV and Lung Neoplasms |
| Lung Diseases | publications with INV and Lung Diseases |
| Heart Diseases | publications with INV and Heart Diseases |
| Liver Neoplasms | publications with INV and Liver Neoplasms |
| Pain | publications with INV and Pain |
| Anemia | publications with INV and Anemia |
Organs/Tissues associated with INV ELISA Kit
| Skin | publications with INV and Skin |
| Brain | publications with INV and Brain |
| Muscle | publications with INV and Muscle |
| Lung | publications with INV and Lung |
| Mouth | publications with INV and Mouth |
| Esophagus | publications with INV and Esophagus |
| Prostate | publications with INV and Prostate |
| Larynx | publications with INV and Larynx |
| Mammary Gland | publications with INV and Mammary Gland |
| Bladder | publications with INV and Bladder |
